Inclusion of the FDG-PET in systematic follow-up of patients with colorectal carcinoma.: Clinical impact.

被引:0
|
作者
Gallego-Peinado, M. [1 ]
Bellon-Guardia, M. [1 ]
Ramos-Font, C. [1 ]
Cabello-Garcia, D. [1 ]
Rodriguez-Fernandez, A. [1 ]
Santiago-Chinchilla, A. [1 ]
Gonzalez-Flores, E. [1 ]
Gutierrez-Sainz, J. [2 ]
Gomez-Rio, M. [1 ]
Llamas-Elvira, J. M. [1 ]
机构
[1] Virgen Las Nievas Hosp, Granada, Spain
[2] Hosp Baza, Baza, Spain
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:S293 / S293
页数:1
相关论文
共 50 条
  • [31] The diagnostic accuracy and clinical impact of FDG-PET/CT follow-up for patients on adjuvant immunotherapy for high-risk malignant melanoma
    Jesper A. S. Andersen
    Anders D. Spatzek
    Mie H. Vilstrup
    Peter Grupe
    Søren Hess
    Paw C. Holdgaard
    Lars Bastholt
    Oke Gerke
    Malene G. Hildebrandt
    European Journal of Nuclear Medicine and Molecular Imaging, 2022, 49 : 2342 - 2351
  • [32] Yield of FDG-PET scanning as a routine follow-up exam in patients with malignancy.
    Jacobson, AF
    Maisey, RN
    Fogelman, I
    Kuhn, D
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (05) : 304P - 304P
  • [33] The diagnostic accuracy and clinical impact of FDG-PET/CT follow-up for patients on adjuvant immunotherapy for high-risk malignant melanoma
    Andersen, Jesper A. S.
    Spatzek, Anders D.
    Vilstrup, Mie H.
    Grupe, Peter
    Hess, Soren
    Holdgaard, Paw C.
    Bastholt, Lars
    Gerke, Oke
    Hildebrandt, Malene G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (07) : 2342 - 2351
  • [34] FDG-PET in immunocompetent patients with primary central nervous system lymphoma: correlation with MRI and clinical follow-up
    H. Palmedo
    H. Urbach
    H. Bender
    U. Schlegel
    I. G. H. Schmidt-Wolf
    A. Matthies
    M. Linnebank
    A. Joe
    J. Bucerius
    H.-J. Biersack
    H. Pels
    European Journal of Nuclear Medicine and Molecular Imaging, 2006, 33 : 164 - 168
  • [35] FDG-PET in immunocompetent patients with primary central nervous system lymphoma: correlation with MRI and clinical follow-up
    Palmedo, H
    Urbach, H
    Bender, H
    Schlegel, U
    Schmidt-Wolf, IGH
    Matthies, A
    Linnebank, M
    Joe, A
    Bucerius, J
    Biersack, HJ
    Pels, H
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 (02) : 164 - 168
  • [36] FDG-PET for prediction of survival of patients with metastatic colorectal carcinoma
    de Geus-Oei, L. F.
    Wiering, B.
    Krabbe, P. F. M.
    Ruers, T. J. M.
    Punt, C. J. A.
    Oyen, W. J. G.
    ANNALS OF ONCOLOGY, 2006, 17 (11) : 1650 - 1655
  • [37] The clinical utility of FDG-PET/CT in follow up and restaging of breast cancer patients
    Emad-Eldin, Sally
    Abdelaziz, Omar
    Harth, Marc
    Hussein, Manar
    Nour-Eldin, Nour-Eldin
    Vogl, Thomas J.
    EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE, 2013, 44 (04): : 937 - 943
  • [38] FDG-PET for prediction of survival of patients with metastatic colorectal carcinoma
    de Geus-Oei, L.
    Wiering, B.
    Krabbe, P. F. M.
    Ruers, T. J. M.
    Punt, C. J. A.
    Oyen, W. J. G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S121 - S121
  • [39] The role of FDG-PET/CT in follow-up of children with lymphoma and osteosarcoma
    Monika, Csoka
    Szatmary, B.
    Muller, J.
    Kovacs, G.
    PEDIATRIC BLOOD & CANCER, 2007, 49 (04) : 521 - 521
  • [40] FDG PET/CT in follow UP patients with colorectal carcinoma after adjuvant chemotherapy
    Elia, Remon Zaher
    Elbastawessy, Rafik Abdelazem
    Abdelmgeguid, Hanaa Abdelkader
    Bassiouny, Ahmed Mohamed
    EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE, 2021, 52 (01):